Fluticasone Propionate And Salmeterol
Also sold as Fluticasone Propionate and Salmeterol, fluticasone propionate and salmeterol, Fluticasone Propionate and Salmeterol DISKUS
Medicine summary · from official FDA labels · Oct 19, 2026
What it’s used for
Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler (FS MDPI) is indicated for the treatment of asthma in adult and pediatric patients aged 12 years and older. Fluticasone Propionate/Salmeterol MDPI should be used for patients not adequately controlled on a long term asthma control medication such as an inhaled corticosteroid or whose disease warrants initiation of treatment with both an inhaled corticosteroid and long acting beta 2 -adrenergic agonist (LABA).
How to take it
For oral inhalation only. ( 2.
Important warnings
5 WARNINGS AND PRECAUTIONS LABA monotherapy increases the risk of serious asthma-related events. ( 5.
Common side effects
The following clinically significant adverse reactions are described elsewhere in the labeling: Serious asthma-related events – hospitalizations, intubations, death [see Warnings and Precautions ( 5. 1 )] Oropharyngeal candidiasis [see Warnings and Precautions ( 5.
Interactions
Fluticasone Propionate/Salmeterol MDPI has been used concomitantly with other drugs, including short‑acting beta 2 ‑agonists, and intranasal corticosteroids, commonly used in patients with asthma without adverse drug reactions [see Clinical Pharmacology ( 12.
If pregnant or breastfeeding
8.
Forms & strengths
0.0275 MG/ACTUAT Nasal Spray · 0.05 MG/ACTUAT Nasal Spray · 0.093 MG/ACTUAT Nasal Spray · 0.00005 MG Topical Ointment · 0.5 MG/ML Topical Cream
Questions to ask your doctor or pharmacist
- Is this the right medicine for my condition, and how long should I take it?
- What side effects should I watch for, and which need urgent attention?
- Does this interact with my other medicines, supplements, or alcohol?
- What should I do if I miss a dose or take too much?